Travere Therapeutics, Inc. (TVTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Travere Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -133.44x | -4.27x | -5.99x | -4.81x | -10.31x | -7.65x |
| P/B Ratio | 29.69x | 23.26x | 3.32x | 31.29x | 6.15x | 6.13x |
| P/S Ratio | 6.95x | 5.89x | 4.60x | 12.25x | 14.09x | 6.53x |
| Profitability | ||||||
| Gross Margin | 97.9% | 96.7% | 92.1% | 96.0% | 97.1% | 96.9% |
| Operating Margin | -12.8% | -138.9% | -267.2% | -292.2% | -151.3% | -88.8% |
| Net Margin | -5.2% | -137.9% | -76.7% | -254.4% | -136.6% | -85.4% |
| EBITDA Margin | 4.5% | -114.0% | -224.6% | -273.5% | -139.9% | -73.2% |
| Liquidity | ||||||
| Current Ratio | 2.74x | 2.08x | 3.47x | 3.42x | 4.70x | 4.43x |
| Quick Ratio | 2.70x | 2.04x | 3.41x | 3.39x | 4.64x | 4.35x |
| Leverage | ||||||
| Debt/Equity | 2.86x | 6.80x | 2.02x | 9.51x | 0.87x | 1.16x |
YoY = year-over-year change. Source: FMP..